Kunming Longjin Pharmaceutical Co Ltd Tangible Net Worth Ratio
Kunming Longjin Pharmaceutical Co Ltd tangible net worth ratio. Kunming Longjin Pharmaceutical Co Ltd (002750) has a Tangible Net Worth Ratio of 84.7% as of March 2025. This metric is calculated by deducting intangible assets (CN¥74.01 Million) from net assets (CN¥485.19 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Kunming Longjin Pharmaceutical Co Ltd (002750) strategic investment index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Kunming Longjin Pharmaceutical Co Ltd (2011–2024)
Tangible net worth ratio of Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2024. This chart shows how Kunming Longjin Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 14 annual periods from 2011 to 2024. As of March 2025, the ratio stands at 84.7%, reflecting net assets of CN¥485.19 Million with intangible assets of CN¥74.01 Million CNY. See working capital to net assets of Kunming Longjin Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Kunming Longjin Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2011–2024)
Kunming Longjin Pharmaceutical Co Ltd tangible net worth ratio by year from 2011 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Kunming Longjin Pharmaceutical Co Ltd (002750) total market value.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 88.2% | CN¥494.21 Million | CN¥58.20 Million | CN¥574.40 Million | ▼ -1.3 pp |
| 2023 | 89.5% | CN¥541.13 Million | CN¥56.81 Million | CN¥631.63 Million | ▼ -3.1 pp |
| 2022 | 92.6% | CN¥604.77 Million | CN¥44.99 Million | CN¥747.21 Million | ▼ -0.5 pp |
| 2021 | 93.0% | CN¥678.29 Million | CN¥47.18 Million | CN¥827.28 Million | ▼ -0.3 pp |
| 2020 | 93.4% | CN¥704.71 Million | CN¥46.70 Million | CN¥841.76 Million | ▲ +0.9 pp |
| 2019 | 92.5% | CN¥665.89 Million | CN¥50.12 Million | CN¥806.89 Million | ▼ -2.8 pp |
| 2018 | 95.3% | CN¥655.93 Million | CN¥31.02 Million | CN¥787.55 Million | ▼ -1.9 pp |
| 2017 | 97.2% | CN¥645.54 Million | CN¥18.38 Million | CN¥785.23 Million | ▼ 0.0 pp |
| 2016 | 97.2% | CN¥670.46 Million | CN¥18.90 Million | CN¥759.68 Million | ▲ +0.4 pp |
| 2015 | 96.8% | CN¥599.41 Million | CN¥19.41 Million | CN¥698.86 Million | ▲ +3.7 pp |
| 2014 | 93.1% | CN¥285.57 Million | CN¥19.85 Million | CN¥435.59 Million | ▼ -0.2 pp |
| 2013 | 93.3% | CN¥302.00 Million | CN¥20.36 Million | CN¥442.56 Million | ▲ +2.5 pp |
| 2012 | 90.8% | CN¥226.94 Million | CN¥20.87 Million | CN¥368.05 Million | ▲ +2.3 pp |
| 2011 | 88.5% | CN¥186.74 Million | CN¥21.38 Million | CN¥287.36 Million | — |